Midfacial swelling and oro-nasal involvement in a 53-year-old patient with bilateral pulmonary infiltrations.
Mavragani
C P
CP
Department of Pathophysiology, Medical School, National University of Athens, Greece.
Paikos
S
S
Doussis-Anagnostopoulou
I
I
Voulgarelis
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000032:analysis / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000032:analysis; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000032:analysis; D014890:Granulomatosis with Polyangiitis / Q000473:pathology; D006801:Humans; D007160:Immunoproliferative Disorders / Q000473:pathology; D007694:Killer Cells, Natural / Q000473:pathology*; D017254:Leukemic Infiltration / Q000473:pathology*; D008171:Lung Diseases / Q000209:etiology / Q000473:pathology*; D008206:Lymphatic Diseases / Q000473:pathology; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy / Q000473:pathology*; D008230:Lymphomatoid Granulomatosis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009669:Nose Neoplasms / Q000188:drug therapy / Q000473:pathology*; D011239:Prednisolone / Q000032:analysis; D014750:Vincristine / Q000032:analysis
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone